首页> 外文期刊>Advanced Biomedical Research >Precalcitonin and C-reactive protein as markers in response to antibiotic treatment in ventilator-associated pneumonia in intensive care unit-hospitalized patients
【24h】

Precalcitonin and C-reactive protein as markers in response to antibiotic treatment in ventilator-associated pneumonia in intensive care unit-hospitalized patients

机译:重症监护病房住院患者呼吸机相关肺炎中降钙素原和C反应蛋白作为抗生素治疗反应的标志物

获取原文
           

摘要

Background: Pneumonia due to ventilator is a prevalent nosocomial infection associated with high morbidity and mortality. This study aimed to determine the change in serum levels of precalcitonin (PCT) and C-reactive protein (CRP) in response to antibiotic treatment in patients hospitalized in intense care unit (ICU) suffering from ventilator-associated pneumonia (VAP). Materials and Methods: This is an analytical and descriptive study performed in 2013 in Ayatollah Kashani Medical Training Center, Isfahan, Iran. The statistical sample includes patients hospitalized in ICU in 2013 suffering from VAP. In this study, 50 patients suffering from VAP were selected, and PCT and CRP levels were measured in them before antibiotic therapy and every 48 h until the end of therapy. The collected data were analyzed by SPSS software. Results: CRP and PCT levels were high before the beginning of antibiotic therapy in all patients suffering from VAP and their CRP level had an increasing trend until 4 days after the beginning of therapy; however, from the 4th day, it turned into decreasing trend. PCT serum level was higher than normal before the treatment and until 48 h after the therapy, and then it was found to have a decreasing trend. According to variance analysis test with repetition of observations, the mean level of mentioned markers had a meaningful difference before the beginning of antibiotic therapy until the end of antibiotic therapy ( P < 0.001). Conclusion: CRP and PCT serum levels can be used as an instrument for determining the effect of antibiotic therapy in patients with VAP.
机译:背景:呼吸机引起的肺炎是一种普遍的医院感染,与高发病率和高死亡率相关。这项研究旨在确定在重症监护病房(ICU)住院的呼吸机相关性肺炎(VAP)患者中抗生素治疗后血清降钙素原(PCT)和C反应蛋白(CRP)的变化。材料和方法:这是2013年在伊朗伊斯法罕的Ayatollah Kashani医学培训中心进行的分析和描述性研究。统计样本包括2013年在ICU住院的VAP患者。在这项研究中,选择了50名患有VAP的患者,并在抗生素治疗之前以及治疗结束前每48小时测量其中的PCT和CRP水平。收集的数据通过SPSS软件进行分析。结果:在所有开始接受VAP治疗的患者中,抗生素治疗开始前的CRP和PCT水平较高,直到开始治疗后4天CRP和PCT的水平仍呈上升趋势。但是,从第4天开始变成下降趋势。 PCT血清水平在治疗前和治疗后48h高于正常水平,然后发现有下降的趋势。根据重复观察的方差分析检验,提到的标志物的平均水平在开始抗生素治疗之前直至结束抗生素治疗之间存在显着差异(P <0.001)。结论:CRP和PCT血清水平可作为测定VAP患者抗生素治疗效果的手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号